Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here.
Yesterday, January 16th, Implant announced that company is hosting a conference call to to update investors on “recent developments”. We emailed our subscribers what to expect from this call:
Implant Sciences (IMSC) is hosting a conference call at 1:30PM EST to update investors on “recent developments”. While it’s trivial, typically, for someone to speculate on the developments a company will announce during such calls, it strikes us as odd that Implant Sciences makes no mention – not even a hint – at what they’re about to discuss.
The most logical conclusion is that the TSA approval that launches IMSC’s trace detection technology in the United States is finally here. This landmark deal has been coming for YEARS.
Our advice? Tune into the call.
We have been right again – in a 5min after opening a conference call IMSC wired a press release:
Implant Sciences Corporation (IMSC) announced today that the U.S. Transportation Security Administration (TSA) has notified the Company that its Quantum Sniffer™ QS-B220 Explosives Trace Detector has successfully met the requirements for acceptance onto the Air Cargo Screening Technology List (ACSTL).
We have previously been compensated in the amount of ten thousand dollars for profiling Implant Sciences on our site. An affiliate of PennyStockHaven.com receives fifteen thousand dollars per month for providing consulting and advisory services to Implant Sciences. We may receive compensation again in the future. This relationship constitutes a conflict and may affect the objectivity of our profile of the company. You should do your own homework and consult an investment professional before making any investment decisions.
Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here.
Yesterday, January 16th, Implant announced that company is hosting a conference call to to update investors on “recent developments”. We emailed our subscribers what to expect from this call:
The most logical conclusion is that the TSA approval that launches IMSC’s trace detection technology in the United States is finally here. This landmark deal has been coming for YEARS.
Our advice? Tune into the call.
Implant Sciences Corporation (IMSC) announced today that the U.S. Transportation Security Administration (TSA) has notified the Company that its Quantum Sniffer™ QS-B220 Explosives Trace Detector has successfully met the requirements for acceptance onto the Air Cargo Screening Technology List (ACSTL).
We have previously been compensated in the amount of ten thousand dollars for profiling Implant Sciences on our site. An affiliate of PennyStockHaven.com receives fifteen thousand dollars per month for providing consulting and advisory services to Implant Sciences. We may receive compensation again in the future. This relationship constitutes a conflict and may affect the objectivity of our profile of the company. You should do your own homework and consult an investment professional before making any investment decisions.